Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sight Sciences, Inc. - Common Stock (NQ:SGHT)

8.420 +0.320 (+3.95%)
Streaming Delayed Price Updated: 10:11 AM EST, Dec 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Sight Sciences, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Sight Sciences (SGHT) Q3 2025 Earnings Transcript ↗
Sight Sciences (SGHT) Q3 2025 Earnings Transcript 
Via The Motley Fool
Topics Intellectual Property World Trade
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
News headline image
Top movers in Friday's session ↗
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Top stock movements in today's session. ↗
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
News headline image
Earnings Scheduled For August 7, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 8, 2025 ↗
 
Via Benzinga
News headline image
Breaking Down Sight Sciences: 6 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
Which stocks are gapping on Friday? ↗
Traders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps. 
Via Chartmill
News headline image
UnitedHealthcare Adds Sight Sciences OMNI System To Covered Glaucoma Surgery Procedures ↗
UnitedHealthcare's new policy covers implant-free glaucoma surgeries like OMNI, supporting treatment for mild to moderate open-angle glaucoma and cataracts. 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About Sight Sciences ↗
 
Via Benzinga
News headline image
The Analyst Verdict: Sight Sciences In The Eyes Of 4 Experts ↗
 
Via Benzinga
News headline image
These stocks are moving in today's pre-market session ↗
Wondering what's happening in Monday's pre-market session? Find an overview in this article. 
Via Chartmill
News headline image
What 6 Analyst Ratings Have To Say About Sight Sciences ↗
 
Via Benzinga
News headline image
Expert Outlook: Sight Sciences Through The Eyes Of 5 Analysts ↗
 
Via Benzinga
News headline image
These stocks are moving in today's pre-market session ↗
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
News headline image
Earnings Scheduled For March 5, 2025 ↗
 
Via Benzinga
News headline image
Where Sight Sciences Stands With Analysts ↗
 
Via Benzinga
News headline image
Sight Sciences: Q4 Earnings Insights ↗
 
Via Benzinga
News headline image
Top 3 Health Care Stocks You'll Regret Missing In November ↗
 
Via Benzinga
News headline image
SGHT Stock Earnings: Sight Sciences Misses EPS, Beats Revenue for Q1 2024 ↗
SGHT stock results show that Sight Sciences missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
Pre-market stock movers are a hot topic this morning as we check out all of the biggest news worth reading about on Wednesday morning! 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Sight Sciences's Earnings: A Preview ↗
 
Via Benzinga
News headline image
Where Sight Sciences Stands With Analysts ↗
 
Via Benzinga
News headline image
SGHT Stock Earnings: Sight Sciences Beats EPS, Misses Revenue for Q4 2023 ↗
SGHT stock results show that Sight Sciences beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth... 
Via Benzinga
News headline image
Earnings Scheduled For March 7, 2024 ↗
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.